Platelet-activating factor plays a role in the mechanism of major histocompatibility complex in T lymphocytes

Immunological Investigations

Volumn 28, Issue 4, 1999, Pages 223-233

  Nikbakht Sangari, M ^a   Qayumi, A K ^a   Keown, P ^a   Duronio, V ^a   Horley, K ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3 BROMO 5 [N PHENYL N [2 [[2 (1,2,3,4 TETRAHYDRO 2 ISOQUINOLYLCARBONYLOXY)ETHYL]CARBAMOYL]ETHYL]CARBAMOYL] 1 PROPYLPYRIDINIUM NITRATE; CD3 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; FLOW CYTOMETRY; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; SWINE DISEASE; T LYMPHOCYTE;

EID: 0032812859     PISSN: 08820139     EISSN: None     Source Type: Journal    
DOI: 10.3109/08820139909060857     Document Type: Article

References (28)

1. Qayumi AK, Nikbakht-Sangari M, Godin DV, English JC, Horley KJ, Keown, SP Lim PA, Ansley DM, Koehle MS. J Cardiovascular and Thoracic Surgery 115(5), 978-89 (1998).
2. F Triebel, S De Roquefeuil, C Blanc, DJ Charron, P Debre, Human immunology 15, 302-315 (1986).
3. S Salvadori, V Pizzimenti, S Cohen, and KS Zier, Clin. Exp. Immunol., 86, 544-549 (1991).
4. AJ Coyle and EP Page, in Platelet-Activating Factor in endotoxin and Immune Diseases, Handley DA, Saunders RN, WJ Houlihan, DC Tomeseh, eds., New York (1990) pp 285-307.
5. KA Milhoan, TA Lane, CM Bloor. Am J Physiol., 263, H956-62 (1992).
6. Y Hamasaki, M Mojarad, T Saga, H Tai, S Said, Am Rev Respir Dis., 120, 742-6 (1984).
7. W Zhou , M McCollum , B Levine, M Olson, Am J Pathol. 140, 971-9 (1991).
8. CA Dinarello, Rev. Infect. Dis., 6, 51-95 (1984).
9. H Hayashi, I Kudo, Inoue K, H Nomura, S Nojima, J. Biochem., 97, 1255-1258 (1985).
10. H Hayashi, I Kudo, K Inoue, K Onozski, S Tsushima, H Nomura, S Nojima, J. Biochem., 97, 1737-1745 (1985).
11. HP Hartung, FEBS Lett., 160, 209-212 (1983).
12. GW Conrad, TJ Rink, J Cell Biol. 102, 439-450 (1986).
13. G Lambrecht, MJ Parnham MJ, Br. J. Pharmacol. 87, 287-289(1986).
14. CA Diarello, New Engl. J. Med., 311, 1413-1419 (1984).
15. KL Erickson, AD Howard, and NE Hubbard, J. Leukocyte Biol., 62, 845-851 (1997).
16. RD Ye, VV Kravchenk, Z Pan, and L Feng., Advances in Experimental Medicine and Biology, 416, 143-51 (1996).
17. C Calabresse, M Cheik Nguer, O Pellegrini, J Benveniste, Y Richard, and Y Thomas, Eur. J Immunol., 22, 1349-1355 (1992).
18. Z Terashita, M Takatani, and K Nishikawa, J Lipid Med., 5, 183-5 (1992).
19. AK Qayumi, JE English, S Duncan, DM Ansley, B Pearson, M Nikbakht-Sangari, C Sammartino, and G Fradet, J. Heart Lung Transpl. , 16(9), 946-55 (1997).
20. S Kishimoto, W Shimadzu, T IzumI, T Shimizu, T Fukuda , S Makino, T Sugiura, and K Waku , J. Immunol., 157, 4126-4132 (1996).
21. S Kishimoto, W Shimadzu, T Izumi, T Shimizu, T Fukuda, S Makino, T Sugiura, and K Waku, Int. Arch. Allergy Immunol. 111(suppl 1), 63-65 (1996).
22. .RM Korth, Int. Arch. Allergy Immunol, 110: 124-131 (1996).
23. RM Korth, M Middeke, Chem. Phys. Lipids, 59, 207-213 (1991).
24. T Kasahara, N Mukaida, K Hatake, K Motoyoshi, T Kawai, K Shiori-Nakane, J. Immun. 134, 1682-1689 (1980).
25. L Osbora, S Kunkel, and GJ Nabel, Proc. Natl. Acad. Sci. USA, 86, 2336-2340, (1989).
26. PA Baeuerle, AD Baltimore, in The hormonal control of gene transcription, Vol. 6., P Cohen and JG Foulkes, eds., Elsevier, Amsterdam, (1994) pp. 423-446.
27. YK Huang, L Schafer-Elinder, H Owman, BJC Lorentzen, J Ronnelid, and J Frostegard, Clin. Exp. Immunol., 106, 143-48 (1996).
28. B Seddon and D Mason, Int. Immunol. 8(8), 1185-1193 (1996).